Hypothesis Chronic rapamycin treatment in aged mice maintains epithelial tight‑junction (TJ) protein levels and low basal permeability but impairs the regenerative response to epithelial injury, resulting in exaggerated inflammaging after barrier challenge.

Rationale Aging reduces ZO‑1 and occludin expression, increasing basal leak and driving systemic NF‑κB activation via luminal LPS and muramyl dipeptide (source; source; source). mTORC1 inhibition by rapamycin preserves baseline TJ integrity in non‑injured epithelium (source), yet genetic mTOR loss in intestinal epithelium causes normal homeostasis but catastrophic repair after irradiation or DSS, with depleted Olfm4+ stem cells (source). ZO‑1 loss similarly uncouples basal barrier from Wnt/β‑catenin‑driven restitution (source). We propose that rapamycin mimics nutrient scarcity, tightening homeostatic TJ assembly while suppressing the anabolic burst needed for rapid TJ restitution and stem‑cell proliferation during repair. Consequently, the barrier appears 'young' at rest but behaves like a damaged, low‑capacity system when injured.

Predictions

1. In aged mice (≥20 mo), rapamycin (8 mg kg⁻¹ d⁻¹, 4 weeks) will not further decrease ZO‑1 or occludin mRNA/protein compared with vehicle, and

Hypothesis

Age‑associated B‑cell dysfunction stems from a NAD+‑SIRT6 metabolic axis that limits chromatin accessibility at immunoglobulin loci, thereby reducing somatic hypermutation and class switch recombination, and it's becoming clear that extrinsic inflammation alone doesn't explain the full phenotype.

Mechanistic Model

• In aged follicular B cells, intracellular NAD+ declines, which lowers SIRT6 deacetylase activity.
• It's known that SIRT6 normally removes acetyl groups from histone H3K9 at the IgH locus; loss of this activity leads to hyperacetylated H3K9, a chromatin state that restricts AID binding.
• Reduced AID access diminishes both replacement mutations in SHM and efficiency of CSR.
• This intrinsic defect persists even when exogenous help is provided, but it's unclear whether the deficit is solely metabolic.
• Inflammatory cytokines such as TNF‑α further destabilize E47 mRNA, compounding the NAD+‑SIRT6 deficit, while altered insulin‑receptor signaling in B cells exacerbates the metabolic imbalance.

Testable Predictions

1. Follicular B cells from donors >65 years will show significantly lower NAD+ levels and higher H3K9ac at the IgH promoter compared with donors <30 years (measured by LC‑MS NAD+ assay and ChIP‑qPCR).
2. Pharmacologic elevation of NAD+ (e.g., nicotinamide riboside) or SIRT6 activation (e.g., MDL‑801) in cultured aged B cells doesn't just raise NAD+ levels; it's expected to restore AID occupancy, increase SHM frequency, and shift Ig secretion from IgM to IgG in vitro.
3. In vivo, aged mice receiving NAD+ precursor supplementation will

Hypothesis

NAD+ decline forms a spatially organized gradient emanating from senescent cell foci, and this gradient functions as a signaling cue that reprograms chromatin in neighboring cells via ADP‑ribosylation of lamina‑associated proteins, thereby locking those cells into a low‑energy, low‑identity state that reinforces tissue aging.

Mechanistic Basis

Senescent cells secrete SASP factors that up‑regulate CD38 in adjacent cells, increasing NAD+ consumption and creating a local NAD+ sink. Falling NAD+ reduces SIRT1 activity, but more importantly, it limits the substrate for nuclear ARTs (ADP‑ribosyltransferases) that modify lamin A/C and lamin B1. When NAD+ is scarce, these lamins become hypo‑ADP‑ribosylated, leading to tighter lamina‑chromatin interactions, reduced accessibility of regeneration‑promoting enhancers, and a shift toward a heterochromatic state. This chromatin change lowers expression of NAD+ biosynthetic genes (NAMPT, NMNAT) and reinforces the sink—a positive feedback loop that spreads the NAD+ low zone outward.

Testable Predictions

1. In aged mouse liver or kidney, high‑resolution spatial transcriptomics will reveal a radial decrease in NAMPT/NMNAT transcripts and a reciprocal increase in CD38/PARP transcripts centered on p16^Ink4a^‑positive senescent cells.
2. Artificially elevating NAD+ locally (e.g., with NMN‑loaded liposomes targeted to senescent cell neighborhoods) will restore lamin ADP‑ribosylation, open chromatin at regenerative loci, and increase proliferative markers in the surrounding tissue.
3. Genetic ablation of CD38 specifically

Hypothesis

Aging‑induced loss of CB1 signaling in the small intestine triggers nuclear accumulation of YAP in enterocytes, which drives a senescence‑associated secretory phenotype (SASP) rich in IL‑6, TNF‑α and matrix metalloproteinases (MMP‑3/9). These SASP factors cleave occludin (but not ZO‑1) at the extracellular loop, increasing paracellular permeability specifically in the small intestine while sparing the colon. The resulting microbial translocation and circulating DAMPs amplify systemic inflammaging. Restoring CB1 activity or inhibiting YAP‑dependent SASP will prevent occludin cleavage, preserve barrier integrity, and reduce systemic inflammatory markers.

Mechanistic Rationale

CB1 receptors normally couple to Gi/o proteins that inhibit cAMP/PKA and suppress YAP translocation via LATS1/2 activation (see CB1‑ZO‑1 mechanism)【https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2023.1241097/full】. In aged enterocytes, ↓CB1 relieves this inhibition, allowing YAP to enter the nucleus. Nuclear YAP cooperates with TEAD transcription factors to upregulate the miR‑17~92 cluster, which targets the mRNA of the senescence suppressor p21^CIP1, thereby promoting p16^INK4a‑dependent senescence【https://doi.org/10.1093/gerona/glt106】. Senescent enterocytes secrete a SASP that includes MMP‑3 and MMP‑9, proteases known to cleave occludin’s extracellular domain, disrupting its homophilic binding without affecting ZO‑1 scaffolding【https://pmc.ncbi.nlm.nih.gov/articles/PMC9427709/】. Occludin loss preferentially increases permeability to bacterial LPS and flage

Hypothesis

Mesenchymal stromal cell (MSC)-derived exosomes that are low in senescence-associated cargo and enriched for miR‑21‑5p through hypoxic preconditioning will exert superior chondroprotective effects compared with exosomes from senescent MSCs, and this effect will be abolished by specific inhibition of miR‑21‑5p.

Rationale

The field recognizes that donor age and senescence status critically shape exosome cargo, with senescent MSC‑exosomes carrying pro‑inflammatory proteins and ECM‑remodeling enzymes that drive secondary senescence {[Senescent cell exosomes exhibit increased inflammatory and ECM‑modifying proteins](https://doi.org/10.1101/2024.06.22.600215]}. Conversely, exosomes from young umbilical cord MSCs can rejuvenate aged MSCs and restore regenerative function {[Exosomes from young MSCs rejuvenate aged MSCs](https://doi.org/10.1186/s13287-020-01782-9]}. However, no trial stratifies donors by senescence biomarkers or uses defined cargo ratios as release criteria. Recent work shows that MSC‑exosomes promote chondrocyte survival and M2 macrophage polarization in osteoarthritis models {[HUCMSCs‑EXOs promote chondrocyte survival and M2 polarization](https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2025.1539714/full]}, yet the mechanistic link between specific exosome microRNAs and chondrocyte homeostasis remains circumstantial due to lack of cargo‑knockout controls {[No studies rigorously isolate paracrine signaling from EV noise via cargo‑knockout controls](https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.20

Hypothesis: The longevity benefits of rapamycin are not solely due to chronic suppression of anabolic growth but arise from its ability to trigger a reversible metabolic state that, when followed by periods of nutrient repletion, activates a coordinated lysosomal‑nuclear repair program. Continuous mTOR inhibition locks cells in a low‑energy, stress‑resistant mode that limits damage accumulation but does not engage the full autophagic‑lysosomal flux needed to remove persistent aggregates such as lipofuscin or cross‑linked proteins. In contrast, an intermittent regimen—rapamycin administered during fasting windows followed by refeeding—creates a hormonal oscillation: mTORC1 inhibition during famine activates TFEB‑driven lysosomal biogenesis and autophagy, while the subsequent refeeding spike raises intracellular NAD+ levels via increased mitochondrial respiration, activating SIRT1 and SIRT3. These sirtuins deacetylate TFEB and other autophagy regulators, enhancing lysosomal acidification and cathepsin activity, thereby converting autophagosome formation into effective cargo degradation. The metabolic switch also transiently elevates AMP‑activated protein kinase (AMPK) and inhibits acetyl‑CoA carboxylase, promoting fatty‑acid oxidation and reducing lipogenesis, which limits new lipid‑based damage formation. Together, this cycle couples damage sequestration (autophagy) with damage clearance (lysosomal degradation) and boosts NAD+-dependent DNA repair pathways (PARP1, SIRT6), addressing both prevention and removal of age‑related lesions.

Testable predictions: (1) Mice r

Hypothesis

Chronic pain perception directly triggers JNK/AP-1 signaling in peripheral and central nociceptive pathways, leading to deposition of the histone variant H2A.J, promotion of cytoplasmic chromatin fragments, and a senescence-associated secretory phenotype (SASP) that accelerates epigenetic aging across tissues, even in the absence of ongoing tissue damage.

Mechanistic Rationale

• Persistent activation of TRPV1/TRPA1 receptors sustains calcium influx and mitochondrial ROS, activating JNK kinases.
• JNK phosphorylates c‑Jun and ATF2, forming AP‑1 complexes that transcriptionally upregulate H2A.J and SASP genes (IL‑6, IL‑8, MMPs).
• H2A.J incorporation into nucleosomes destabilizes chromatin, facilitating release of DNA fragments into the cytoplasm where they activate cGAS‑STING, further amplifying JNK/AP‑1 signaling in a feed‑forward loop.
• This loop mirrors the stress‑induced senescence pathway described in Drosophila, where JNK/AP‑1 is sufficient to induce SASP‑like states, and extends it to mammalian nociceptors and glial cells.

Testable Predictions

1. In mice with induced chronic neuropathic pain (e.g., spared nerve injury), dorsal root ganglia and spinal cord will show increased H2A.J foci and cytoplasmic chromatin within 7 days, preceding measurable epigenetic age acceleration.
2. Pharmacological inhibition of JNK (using SP600125) or genetic deletion of H2A.J in nociceptors will block SASP cytokine release and prevent epigenetic age acceleration despite persistent pain behavior.
3. Conversely, chemogenetic activation of TRPV1 in pain‑free mice w

Hypothesis

Sustained elevation of the ketone body β‑hydroxybutyrate (βHB) directly activates the ULK1 complex via HDAC inhibition and HCAR2‑mediated AMPK signaling, and this molecular event is the true gatekeeper of autophagic flux during fasting. Consequently, the duration of fasting required to stimulate autophagy varies inter‑individually based on how quickly an individual reaches a threshold βHB concentration that reliably triggers ULK1 activation, which in turn is dictated by baseline metabolic flexibility.

Mechanistic Reasoning

1. βHB as a signaling molecule – Beyond its role as an oxidative substrate, βHB inhibits class I HDACs, leading to increased acetylation of autophagy‑related genes (e.g., LC3B, BECN1) and promotes AMPK activation through the HCAR2 receptor. Both pathways converge on ULK1 Ser‑555 phosphorylation, the critical step for autophagosome initiation.
2. Metabolic flexibility determines ketogenesis speed – Individuals with low fasting RER (high fat oxidation) deplete hepatic glycogen faster and achieve βHB ≥ 0.5 mM within ~12–16 h, whereas metabolically inflexible subjects (high fasting RER) require >24 h to reach the same ketone level due to larger glycogen reserves and impaired hepatic mitochondrial oxidation.
3. Flux versus induction – Measuring LC3‑II/p62 alone conflates autophagosome formation with blocked degradation. By coupling βHB levels with a tandem mCherry‑GFP‑LC3 reporter (or lysosomal inhibition assay using bafilomycin A1) we can distinguish true flux (GFP loss, mCherry retention) from mere induction.

Testable Pr

Hypothesis

We hypothesize that chronic exposure of aged osteoblasts to senescence-associated secretory phenotype (SASP) factors from immune cells directly inhibits the vitamin K‑dependent γ‑glutamyl carboxylase (GGCX) activity, leading to elevated noncarboxylated osteocalcin and defective hydroxyapatite nucleation.

Rationale

• Aged humans show increased serum noncarboxylated osteocalcin (1.59 ± 1.1 ng/ml) versus premenopausal levels (0.65 ± 0.5 ng/ml) despite adequate vitamin K, indicating a block in the carboxylation step {[https://pubmed.ncbi.nlm.nih.gov/1666807/]}
• Carboxylated osteocalcin binds hydroxyapatite with high affinity; its deficiency reduces crystal nucleation and promotes larger, brittle crystals {[https://pubmed.ncbi.nlm.nih.gov/11368299/]; [https://repository.lsu.edu/cgi/viewcontent.cgi?article=3338&context=gradschool_theses]}
• Osteoblasts from aged mice exhibit reduced expression of bone matrix proteins and this phenotype is retained in stromal stem cells, pointing to an upstream dysregulation {[https://pubmed.ncbi.nlm.nih.gov/37519232/]}
• Senescent immune cells accumulate with age and secrete a SASP rich in IL‑6, TNF‑α, ROS, and prostaglandins that can alter enzyme activity in neighboring cells {[https://pubmed.ncbi.nlm.nih.gov/29563310/]}

Mechanistic Model

1. SASP cytokines (e.g., TNF‑α) activate NF‑κB signaling in osteoblasts, which upregulates expression of microRNA‑122 that directly represses GGCX translation.
2. Oxidative metabolites from SASP (e.g., H₂O₂) oxidize the reduced vitamin K hydroquinone cofactor, rendering it unavailable fo

HIF-1α as a Developmental Switch Governing the Hallmarks of Aging

Mechanistic Rationale

HIF-1α is best known as an oxygen-sensor, but recent work shows it can also shape epigenetic landscapes, mitochondrial metabolism, and inflammatory signaling—processes that map onto the classic hallmarks of aging. In neurons, HIF-1α drives a glycolytic shift that raises lactate, which in turn inhibits histone deacetylases and promotes a more permissive chromatin state. This epigenetic drift mirrors the epigenetic clock’s acceleration seen with age. Simultaneously, HIF-1α-dependent up-regulation of LDHA and PDK1 suppresses pyruvate flux into the TCA cycle, increasing mitochondrial ROS and triggering mitophagy failure—a core element of mitochondrial dysfunction. Finally, HIF-1α can potentiate NF-κB activity by stabilizing its p65 subunit, amplifying the senescence-associated secretory phenotype (SASP) and linking hypoxia signaling to inflammaging.

Why Crocetin Matters

Crocetin, a carotenoid derivative of saffron, has been shown to indirectly affect HIF-1α in cancer cells through the miR-320/KLF5 axis. Although direct binding data are lacking, the structural similarity of crocetin to other polyene ligands that chelate Fe²⁺ raises the possibility that it could modulate PHD activity, akin to quercetin’s Fe²⁺ chelation. Importantly, crocetin’s BBB permeability is low (log P_app = 0.10) and it is a P‑gp substrate, meaning its central nervous system exposure depends on efflux dynamics that shift with age. Age-related BBB remodeling replaces receptor-mediated transport with less efficie

Hypothesis

Age‑related decline in tropoelastin synthesis in the abdominal infrarenal aorta increases matrix stiffness sensed by vascular smooth muscle cells, driving nuclear translocation of YAP/TAZ and promoting an osteogenic phenotypic switch that leads to medial calcification. This mechanism explains regional susceptibility to stiffness and calcification beyond passive collagen accumulation.

Mechanistic Basis

• It's known that elastin fragments normally engage integrin‑αvβ3 to suppress FAK‑Src signaling; loss of tropoelastin reduces this brake, elevating focal adhesion kinase activity.
• heightened FAK‑Src activates the Hippo pathway antagonists LATS1/2, allowing YAP/TAZ to accumulate in the nucleus.
• Nuclear YAP/TAZ complexes with TEAD transcription factors to upregulate Runx2, Osterix and BMP2, orchestrating VSMC‑derived hydroxyapatite deposition.
• Low nitric oxide in the infrarenal aorta amplifies ROS‑mediated inhibition of phosphatases, further sustaining FAK‑Src activity.
• Thus, active VSMC mechanotransduction couples elastin loss to calcification, synergizing with passive collagen‑elastin imbalance described in aging mice Aging exacerbates stiffness via increased collagen, elastin fragmentation, VSMC dysfunction, and pressure‑dependent recruitment of stiffer collagen fibers.

Testable Predictions

1. VSMC‑specific knockdown of tropoelastin in aged mice will increase nuclear YAP/TAZ staining and medial calcium content; we don't expect collagen deposition to change significantly.
2. It's possible that

Background Partial reprogramming with OSK factors (Oct4, Sox2, Klf4) reverses epigenetic age and extends lifespan in aged mice, yet the benefits decline after transient expression and optimal re‑dosing intervals remain unknown【https://rejuvenatebio.com/press-releases/rejuvenate-bio-announces-gene-therapy-mediated-partial-reprogramming-extends-lifespan-and-reverses-age-related-changes-in-the-journal-cellular-reprogramming】. DNA methylation clocks provide a quantitative, tissue‑agnostic readout of epigenetic age that could serve as a feedback signal for adaptive therapy, but no published 2023‑2025 study has implemented a closed‑loop system where clock readouts directly regulate OSK expression.

Hypothesis We hypothesize that a methylation‑responsive OSK circuit—where OSK transcription is driven by a synthetic promoter whose activity increases with rising methylation at clock‑associated CpGs and falls as those sites become demethylated—will create a self‑limiting, homeostatic rejuvenation system. This adaptive OSK expression will maintain tissue epigenetic age within a youthful range, prolong functional benefits, and avoid the over‑reprogramming risks (e.g., delayed wound healing, tumorigenicity) seen with fixed‑dose regimens.

Mechanistic Rationale

1. OSK induces TET1/2‑dependent demethylation of CpG sites that are core components of the mouse Horvath‑type methylation clock【https://pmc.ncbi.nlm.nih.gov/articles/PMC7752134/】. As these sites lose methylation, the clock’s estimated epigenetic age decreases.
2. Conversely, age‑associated gain of methylation at the same CpGs recru

Hypothesis

Aged cells actively suppress autophagy through a NAD+-sensitive SIRT1/TFEB axis that is further locked in by inflammasome‑driven caspase‑1 cleavage of TFEB and lysosomal membrane proteins, creating a self‑reinforcing loop that preserves damaged macromolecules as a stress‑adaptation reserve.

Mechanistic Basis

• NAD+ decline reduces SIRT1 deacetylase activity, limiting TFEB nuclear translocation and lysosomal biogenesis[https://pmc.ncbi.nlm.nih.gov/articles/PMC12986615/].
• Persistent mTORC1 activity phosphorylates ULK1 (Ser758), blocking autophagosome initiation even under starvation[https://pmc.ncbi.nlm.nih.gov/articles/PMC6398527/].
• Chronic inflammation and mtROS activate the NLRP3 inflammasome, leading to caspase‑1–mediated cleavage of TFEB at Asp215, generating a truncated TFEB that cannot drive lysosomal gene expression[https://www.nature.com/articles/s41467-020-15478-9].
• Cleaved TFEB acts as a dominant‑negative isoform, sequestering full‑length TFEB in the cytoplasm and reducing transcription of Atg genes[https://www.cell.com/molecular-cell/fulltext/S1097-2765(20)00428-5].
• The resulting autophagy insufficiency fuels further mtROS and inflammasome activation, closing a feedback loop[https://www.nature.com/articles/nrm.2020.30].

Novel Insight

We propose that the inflammasome‑TFEB cleavage is the decisive switch that converts reversible mTORC1‑mediated suppression into a semi‑stable, senescence‑associated autophagy block. Unlike mTOR inhibition alone, blocking caspase‑1 should restore TFEB flux even when NAD+ remains low, because it removes t

Hypothesis

In aging bone, vitamin K–mediated gamma‑carboxylation of osteocalcin (cOC) directly inhibits hydroxyapatite (HA) nucleation and crystal elongation. When cOC levels fall—due to reduced vitamin K availability or impaired carboxylation—HA crystals enlarge, increasing stiffness and brittleness while altering fluid shear stress in the lacunar‑canicular network and diminishing osteocyte mechanosensitivity. Restoring cOC through vitamin K supplementation will therefore attenuate HA crystal growth, improve osteocyte signaling, and reduce age‑related bone fragility.

Mechanistic Rationale

• Carboxylated osteocalcin possesses a high affinity for calcium phosphate surfaces; its glutamic acid residues bind to nascent HA facets, sterically blocking further ion addition (https://pubmed.ncbi.nlm.nih.gov/1666807/).
• Uncarboxylated osteocalcin (ucOC) lacks these negatively charged groups, showing minimal interaction with HA and thus failing to restrain crystal maturation.
• Age‑related declines in vitamin K status or warfarin‑like interference lower the cOC/ucOC ratio, permitting uncontrolled HA growth (https://pubmed.ncbi.nlm.nih.gov/40794153/, https://pubmed.ncbi.nlm.nih.gov/30315999/).
• Enlarged HA crystals increase matrix stiffness, which dampens fluid flow-induced shear stress on osteocyte processes, lowering nitric oxide and prostaglandin signaling pathways that normally stimulate bone formation and suppress sclerostin ([https://pubme

Hypothesis

In aging, protein aggregates are not merely garbage but serve as redox‑buffering scaffolds that trap reactive oxygen species (ROS) and redox‑active metals. When autophagy is enhanced (e.g., by disrupting the BCL‑2/Beclin‑1 interaction) these aggregates are dismantled, releasing the sequestered oxidants. If the cell’s antioxidant capacity is not simultaneously upregulated, the sudden increase in bioavailable ROS causes oxidative damage that outweighs the benefit of aggregate removal. Thus, lifespan extension from autophagy activation depends on coupling aggregate clearance with bolstered antioxidant defenses.

Mechanistic Reasoning

1. Aggregate composition – Age‑related insolubility studies show enrichment of cysteine‑rich, metal‑binding proteins (e.g., SOD1, ferritin) within aggregates [PMC3501694]; these proteins can chelate Fe²⁺/Cu⁺ and scavenge ROS.
2. Autophagy‑dependent release – Genetic disruption of BCL‑2/Beclin‑1 increases basal autophagy and reduces aggregate load [PMC5992097]; we predict this process liberates bound metals and ROS into the cytosol.
3. Redox imbalance – Aged brains exhibit ~20 % slower protein turnover and accumulating aggregates [sciadv.abn4437]; simultaneously, antioxidant enzymes (e.g., glutathione peroxidase) decline with age, creating a vulnerable redox environment.
4. Phenotypic outcome – If released oxidants exceed scavenging capacity, lipid pero

Hypothesis

In aged bone marrow, hyperactive mTORC1 in niche macrophages actively suppresses autophagy, leading to accumulation of damaged mitochondria and elevated ROS. This oxidative environment modifies core autophagy proteins (e.g., LC3, ATG7) in adjacent erythroid progenitors, preventing lipidation and autophagosome formation even when EPO stimulates Akt/Erk1/2/BAD pathways. Consequently, EPO fails to induce protective autophagy, resulting in ineffective erythropoiesis and anemia despite high circulating EPO.

Mechanistic Rationale

• mTORC1 hyperactivation in senescent macrophages inhibits autophagosome formation via ULK1 phosphorylation [[https://doi.org/10.1016/j.exger.2014.11.004]].
• Impaired autophagy in macrophages causes mitochondrial dysfunction and ROS spillover [[https://pmc.ncbi.nlm.nih.gov/articles/PMC4058053/]].
• ROS can oxidize cysteine residues on LC3 and ATG3, blocking LC3‑II conjugation and autophagosome expansion—a mechanism not yet tested in erythroid progenitors [[https://pmc.ncbi.nlm.nih.gov/articles/PMC9527112/]].
• EPO‑triggered Akt/Erk1/2/BAD signaling normally promotes autophagy, but oxidative inhibition of the conjugation machinery uncouples this signal from functional autophagic flux.

Testable Predictions

1. Aged marrow macrophages will show higher p62 accumulation and lower LC3‑II/I ratios compared with young controls, indicative of suppressed autophagy.
2. ROS levels in the macrophage‑derived supernatant will correlate positively with oxidative modifications of LC3 in co‑cultured erythroid progenitors.
3. Pharmacological or geneti

Hypothesis

The hierarchy of selective autophagy is not static but is rewired each day by a circadian phospho‑switch on the receptor p62/SQSTM1. During the light phase, CK1ε phosphorylates p62 at Ser403, increasing its affinity for K63‑linked ubiquitin chains while reducing LC3 interaction. This biases the receptor‑driven, cargo‑first pathway toward removal of damaged mitochondria and protein aggregates. In the dark phase, dephosphorylation by PP1 restores balanced p62‑LC3 binding, allowing bulk, starvation‑induced autophagy to dominate and sustain amino‑acid recycling. Disruption of this phospho‑cycle—through chronic light‑at‑night, aging‑related kinase decline, or phospho‑dead mutants—locks p62 in a state that preferentially engages bulk autophagy, depriving the cell of timely selective clearance and leading to accumulation of toxic cargo, mitochondrial dysfunction, and inflammaging.

Testable Predictions

1. Phospho‑specific antibodies will show peak p62‑Ser403 phosphorylation in mouse liver at ZT6 (mid‑light) and nadir at ZT18 (mid‑dark).
2. Liver‑specific expression of a phospho‑dead p62‑S403A mutant will flatten the circadian rhythm of autophagosome abundance, increase basal LC3‑II levels, and reduce mitochondrial protein turnover measured by pulse‑chase labeling of COXIV.
3. Conversely, a phospho‑mimetic p62‑S403D will enhance mitochondrial clearance during the light phase, increase mitophagy flux (mt‑Keima), and improve glucose tolerance in aged mice.
4. Chronic exposure to dim light at night will dampen p62‑Ser403 phosphorylation, shift autophagy toward bul

Hypothesis

Aged erythroid progenitors develop EPO resistance not only through reduced EPO-R expression but via inflammasome‑dependent SOCS3 accumulation that blocks JAK2 phosphorylation and promotes its lysosomal degradation. Chronic marrow inflammation activates NLRP3 inflammasome, leading to caspase‑1‑mediated IL‑1β release and upstream NF‑κB‑driven SOCS3 transcription. Simultaneously, age‑related decline in autophagic flux prevents clearance of SOCS3 aggregates, creating a feed‑forward loop that sustains JAK2 inhibition and diminishes STAT5 signaling. This mechanism links the niche‑derived inflammatory milieu to metabolic inflexibility: SOCS3‑bound JAK2 fails to activate PI3K‑AKT, lowering glycolysis and HIF‑1α stabilization, further blunting EPO‑driven erythropoiesis. We predict that restoring autophagy—through intermittent fasting, spermidine, or genetic upregulation of ATG7 in erythroid progenitors—will degrade SOCS3, rescue JAK2/STAT5 signaling, and improve EPO sensitivity without exacerbating marrow adiposity or bone loss.

Testable predictions

1. SOCS3 protein levels will be significantly higher in CD71+Ter119+ erythroid progenitors from 24‑month‑old mice vs 3‑month‑old controls, correlating with increased NLRP3 inflammasome activity (ASC speck formation) and phospho‑JAK2(Y1007/1008) reduction.[https://pmc.ncbi.nlm.nih.gov/articles/PMC2805199/][https://pmc.ncbi.nlm.nih.gov/articles/PMC12809054/]
2. Pharmacologic or genetic autophagy induction (e.g., 24‑h fasting cycles, rapamycin treatment, or erythroid‑specific ATG7 overexpression) will reduce SOC